These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33521579)

  • 1. Vaccination Against SARS-CoV-2 in Immunosuppressed Patients with Rheumatic Diseases: Position Statement of the Greek Rheumatology Society.
    Greek Rheumatology Society and Professional Association of Rheumatologists (ERE-EPERE)
    Mediterr J Rheumatol; 2020 Dec; 31(4):430-432. PubMed ID: 33521579
    [No Abstract]   [Full Text] [Related]  

  • 2. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.
    Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H
    Z Rheumatol; 2021 Dec; 80(Suppl 2):33-48. PubMed ID: 34491403
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases : Recommendations of the German Society for Rheumatology for physicians and patients].
    Specker C; ; Schulze-Koops H;
    Z Rheumatol; 2021 Feb; 80(1):43-44. PubMed ID: 33438061
    [No Abstract]   [Full Text] [Related]  

  • 4. Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening).
    Cuadros EN; Calzada-Hernández J; Clemente D; Martín SG; Silveira LF; Lirola-Cruz MJ; Tagarro A; Lovillo MC; Rueda RMA; López AL; Aritziturri MS; Calvo C
    Eur J Pediatr; 2022 Jun; 181(6):2343-2354. PubMed ID: 35258699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].
    Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H
    Z Rheumatol; 2021 Aug; 80(6):570-587. PubMed ID: 34309739
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
    Glintborg B; Jensen DV; Terslev L; Hendricks O; Østergaard M; Rasmussen SH; Jensen MP; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Sørensen CM; Krogh NS; Agerbo JN; Ziegler C; Hetland ML
    J Rheumatol; 2022 Oct; 49(10):1163-1172. PubMed ID: 35705237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.
    Liew J; Gianfrancesco M; Harrison C; Izadi Z; Rush S; Lawson-Tovey S; Jacobsohn L; Ja C; Hyrich KL; Gossec L; Strangfeld A; Carmona L; Schäfer M; Frãzao-Mateus E; Bulina I; Stafford F; Tufan A; Graver C; Yardımcı GK; Zepa J; Al Emadi S; Cook C; Abutiban F; Dey D; Katigbak G; Kaufman L; Kowalski E; Martínez-Martínez MU; Patel NJ; Reyes-Cordero G; Salido E; Smith E; Snow D; Sparks J; Wise L; Bhana S; Gore-Massy M; Grainger R; Hausmann J; Sirotich E; Sufka P; Wallace Z; Machado PM; Robinson PC; Yazdany J
    RMD Open; 2022 Apr; 8(1):. PubMed ID: 35387864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 vaccination in patients with inflammatory bowel disease.
    Prentice RE; Rentsch C; Al-Ani AH; Zhang E; Johnson D; Halliday J; Bryant R; Begun J; Ward MG; Lewindon PJ; Connor SJ; Ghaly S; Christensen B
    GastroHep; 2021 Jul; 3(4):212-228. PubMed ID: 34539248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
    Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
    Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
    Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K
    Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information.
    Schulze-Koops H; Krüger K; Hoyer BF; Leipe J; Iking-Konert C; Specker C;
    Rheumatology (Oxford); 2021 May; 60(5):2128-2133. PubMed ID: 33502500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.
    Alexander JL; Moran GW; Gaya DR; Raine T; Hart A; Kennedy NA; Lindsay JO; MacDonald J; Segal JP; Sebastian S; Selinger CP; Parkes M; Smith PJ; Dhar A; Subramanian S; Arasaradnam R; Lamb CA; Ahmad T; Lees CW; Dobson L; Wakeman R; Iqbal TH; Arnott I; Powell N;
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):218-224. PubMed ID: 33508241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseases.
    Shen M; Dong L; Li M; Zhao Y; Zeng X;
    Rheumatol Immunol Res; 2021 Dec; 2(4):213-216. PubMed ID: 35772082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.
    Tavares ACFMG; de Melo AKG; Cruz VA; de Souza VA; de Carvalho JS; Machado KLLL; de Azevedo Valadares LD; Dos Reis Neto ET; de Rezende RPV; de Resende Guimarães MFB; Ferreira GA; de Sousa Braz A; de Abreu Vieira RMR; de Medeiros Pinheiro M; Ribeiro SLE; Bica BEGR; Baptista KL; da Costa IP; Marques CDL; Lopes MLL; Martinez JE; Giorgi RDN; da Mota LMH; da Rocha Loures MAA; Dos Santos Paiva E; Monticielo OA; Xavier RM; Kakehasi AM; Pileggi GCS
    Adv Rheumatol; 2022 Jan; 62(1):3. PubMed ID: 35039077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases.
    Yeo JG; Chia WN; Teh KL; Book YX; Hoh SF; Gao X; Das L; Zhang J; Sutamam N; Lim AJM; Poh SL; Tay SH; Nay Yaung K; Ong XM; Hazirah SN; Chua CJH; Leong JY; Wang LF; Albani S; Arkachaisri T
    Rheumatology (Oxford); 2022 Nov; 61(11):4472-4481. PubMed ID: 35199166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Tofacitinib in the Context of COVID-19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases.
    Mortezavi M; Menon S; Lee K; Rivas J
    Arthritis Rheumatol; 2021 Sep; 73(9):1768-1769. PubMed ID: 34042319
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study.
    Aikawa NE; Kupa LVK; Pasoto SG; Medeiros-Ribeiro AC; Yuki EFN; Saad CGS; Pedrosa T; Fuller R; Shinjo SK; Sampaio-Barros PD; Andrade DCO; Pereira RMR; Seguro LPC; Valim JML; Waridel F; Sartori AMC; Duarte AJS; Antonangelo L; Sabino EC; Menezes PR; Kallas EG; Silva CA; Bonfa E
    Lancet Rheumatol; 2022 Feb; 4(2):e113-e124. PubMed ID: 34901885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases.
    Paik JJ; Sparks JA; Kim AHJ
    Curr Opin Pharmacol; 2022 Aug; 65():102243. PubMed ID: 35636384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.
    Ko T; Dendle C; Woolley I; Morand E; Antony A
    Hum Vaccin Immunother; 2021 Nov; 17(11):4048-4056. PubMed ID: 34357827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.